Navigation Links
New report shows diagnosed diabetes, pre-diabetes, and gestational diabetes is on the rise among privately insured Americans
Date:12/15/2013

Washington, DCAbout 8.8 percent of the privately insured population in 2012 had diabetes or was diagnosed as being at high risk for diabetes, up from 8.3 percent in 2011, but the rates of disease varied depending on age, gender and region of the country, says a new report from HCCI. In 2012, over one quarter of men between the ages of 55-64 and nearly one in 10 Southerners had diabetes or were at risk for diabetes.

HCCI analyzed the health care claims of over 40 million Americans with employer-sponsored health insurance (ESI) from 2008 to 2012, and examine subpopulations by age, gender, and region. HCCI identified individuals with "diabetes" as those diagnosed with diabetes and those at high risk for developing diabetes (diagnosed with gestational diabetes or pre-diabetes).

"This is the first time we've used our repository of claims data to track the prevalence of chronic disease among the privately insured," said David Newman, Executive Director of HCCI. "While using claims data for public health surveillance purposes has some limitations, it provides a timely way to track emerging trends and can inform policymakers, providers, and patients alike."

Here are key findings from the report:

  • Population Prevalence: HCCI identified 6.4 percent of the privately insured as having diabetes or at high risk for diabetes in 2008. By 2012, the prevalence of diagnosed diabetes, pre-diabetes, and gestational diabetes reached 8.8 percent.

  • Age: Diabetes was most prevalent in older adults. In 2012, the prevalence of diagnosed diabetes, pre-diabetes, and gestational diabetes was 14.3 percent among privately insured adults ages 45 to 54, and 26.3 percent among adults ages 55 to 64.

  • Gender: In 2012, 9.1 percent of men and 8.4 percent of women were identified as having diagnosed diabetes, pre-diabetes, and gestational diabetes. Compared to men of the same age, women between the ages of 19 and 44 had higher prevalence. However, after age 45, the prevalence rates for men rapidly outpaced that of women.

  • Region: Prevalence was highest in the Mid-Atlantic, South Atlantic, and East South Central census divisions, where nearly 10 percent of people with employer-sponsored insurance were diagnosed with diabetes, pre-diabetes, and gestational diabetes in 2012. Prevalence was lowest in the Mountain, Pacific, and New England census divisions.


'/>"/>

Contact: Jemma Weymouth
jweymouth@burnesscommunications.com
301-280-5706
Burness Communications
Source:Eurekalert

Related medicine news :

1. Global Wireless Gigabit (WiGig) Market Worth $ 4.8 Billion by 2018 - New Report by MarketsandMarkets
2. Silicon Photonics Market worth $2.02 Billion by 2015 - New Report by MarketsandMarkets
3. Nuclear Medicine / Radiopharmaceutical Market is worth $5.55 Billion by 2017 - New Report by MarketsandMarkets
4. Editing & Proofreading Services Procurement Research Report Now Available from IBISWorld
5. Judge Overseeing Federal Biomet Hip Lawsuits Won't Name Special Discovery Master, Bernstein Liebhard LLP Reports
6. Nutrition report cards receive high marks in pilot program
7. Vaginal Mesh Lawsuit News: Federal Judge Overseeing American Medical Systems Litigation Sets Order of First Bellwether Trials, Bernstein Liebhard LLP Reports
8. Full-Service Restaurants in Canada Industry Market Research Report from IBISWorld Has Been Updated
9. Activated Carbon Manufacturing in the US Industry Market Research Report Now Available from IBISWorld
10. Global Kidney Transplantation Clinical Trials Review 2013: Worldwide Industry Share, Investment Trends, Growth, Size, Strategy And Forecast Research Report 2013
11. Fosamax Lawsuits Update: Rottenstein Law Group LLP Comments on Reported $28 Million Merck ‘Jaw Death’ Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... “The Journey: ... faced every danger possible to save lost souls in the Philippines. “The Journey: From ... Carole is a dedicated teacher of the Bible. She has taught all ages and ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... that we intend to develop to enable prevention of a major side effect ... hearing loss, especially in pediatric patients. For cisplatin, hearing loss is FDA listed ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
(Date:9/12/2017)... and NEW YORK , Sept. 12, 2017 ... performance ratings for global supply chains, has published the first annual edition ... CSR performance of more than 20,400 companies evaluated by EcoVadis, based on ... 2015 and 2016. ... EcoVadis Global CSR Risk & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., ... Solutions (VLMS), is pleased to announce the appointment ... member of its Board of Directors and Chairman ... VLMS enables life science companies to manage their ... use of paper in this process. Furthermore, ValGenesis ...
Breaking Medicine Technology: